Role of preoperative breast MRI in ductal carcinoma in situ for prediction of the presence and assessment of the extent of occult invasive component

Breast Journal

Volumn 20, Issue 3, 2014, Pages 243-248

  Nori, Jacopo ^a   Meattini, Icro ^a   Giannotti, Elisabetta ^a   Abdulcadir, Dalmar ^a   Mariscotti, Giovanna ^b   Calabrese, Massimo ^c   Angelino, Francesca ^b   Chiesa, Fabio ^c   Saieva, Calogero ^d   Vanzi, Ermanno ^a   Boeri, Cecilia ^a   Bianchi, Simonetta ^a   Sanchez, Luis ^a   Orzalesi, Lorenzo ^a   Casella, Donato ^a   Susini, Tommaso ^a   Livi, Lorenzo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

breast cancer; ductal carcinoma in situ; extent disease; occult invasive component; preoperative MR imaging

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MAMMOGRAPHY SYSTEM; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARTIAL MASTECTOMY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; TUMOR INVASION; TUMOR VOLUME; AGE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PREOPERATIVE CARE; PROCEDURES; RADIOGRAPHY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84899126993     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12250     Document Type: Article

References (32)

1. Mossa-Basha M, Fundaro GM, Shah BA, Ali S, Pantelic MV,. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation. Radiographics 2010; 30: 1673-87.
2. Stomper PC, Herman S, Klippenstein DL, et al,. Suspect breast lesions:findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197: 387-95.
3. Podo F, Sardanelli F, Canese R, et al,. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002; 21: S115-24.
4. Buadu LD, Murakami J, Murayama S, et al,. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996; 200: 639-49.
5. Viehweg P, Lampe D, Buchmann J, Heywang-Köbrunner SH,. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging. MAGMA 2000; 11: 129-37.
6. Harms SE, Flaming DP, Hesley KL, et al,. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187: 493-501.
7. Orel SG, Mendonca MH, Reynolds C, Schnall MD, Solin LJ, Sullivan DC,. MR imaging of ductal carcinoma in situ. Radiology 1997; 202: 413-42.
8. Berg WA, Gutierrez L, Nessavier MS, et al,. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer: evidence for improved preoperative staging. Radiology 2004; 233: 830-49.
9. Medeiros LR, Duarte CS, Rosa DD, et al,. Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis. Breast Cancer Res Treat 2011; 126: 273-85.
10. Deurloo EE, Sriram JD, Teertstra HJ, et al,. MRI of the breast in patients with DCIS to exclude the presence of invasive disease. Eur Radiol 2012; 22: 1504-11.
11. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L,. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005; 11: 382-90.
12. Santamaría G, Velasco M, Farrús B, Zanón G, Fernández PL,. Preoperative MRI of pure intraductal breast carcinoma-a valuable adjunct to mammography in assessing cancer extent. Breast 2008; 17: 186-94.
13. Schouten van der Velden AP, Boetes C, Bult P, Wobbes T,. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006; 192: 172-8.
14. Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS,. Pure ductal carcinoma in situ: kinetic and morphologic Mr characteristics compared with mammographic appearance and nuclear grade. Radiology 2007; 245: 684-91.
15. Groves AM, Warren RM, Godward S, Rajan PS,. Characterization of pure high-grade DCIS on magnetic resonance imaging using the evolving breast MR lexicon terminology: can it be differentiated from pure invasive disease? Magn Reson Imaging 2005; 23: 733-8.
16. Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM,. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 2003; 10: 381-8.
17. Balleyguier C, Ayadi S, Van Nguyen K, Vanel D, Dromain C, Sigal R,. BIRADS classification in mammography. Eur J Radiol 2007; 61: 192-4.
18. Huang YT, Cheung YC, Lo YF, Ueng SH, Kuo WL, Chen SC,. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy. Acta Radiol 2011; 52: 1064-8.
19. Van Goethem M, Schelfout K, Kersschot E, et al,. Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. JBRT-BTR 2005; 88: 225-32.
20. Bazzocchi M, Zuiani C, Panizza P, et al,. Contrast-Enhanced Breast MRI in patients with suspicious microcalcifications on mammography: results of multicenter trial. AJR 2006; 186: 1723-32.
21. Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD,. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J 2007; 13: 545-50.
22. Kim DY, Moon WK, Cho N, et al,. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean Journal of Radiology 2007; 1: 32-9.
23. Kuhl CK, Schrading S, Bieling HB, et al,. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007; 370: 485-92.
24. Vag T, Baltzer P, Renz D, et al,. Diagnosis of ductal carcinoma in situ using contrast-enhanced magnetic resonance mammography compared with conventional mammography. Clin Imaging 2008; 32: 438-42.
25. Goto M, Yuen S, Akazawa K, et al,. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. Eur Radiol 2012; 22: 1255-64.
26. Liu H, Peng W,. MRI morphological classification of ductal carcinoma in situ (DCIS) correlating with different biological behavior. Eur J Radiol 2012; 81: 214-7.
27. Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA,. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology 2005; 235: 791-7.
28. Mahfouz AE, Sherif H, Saad A, et al,. Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity? Eur Radiol 2001; 11: 965-9.
29. Sardanelli F,. Vascular maps on contrast-enhanced breast MR images: a new approach requiring further investigation. Radiology 2008; 247: 295-6.
30. Schmitz AC, Peters NH, Veldhuis WB, et al,. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps. Eur Radiol 2008; 18: 355-64.
31. Martincich L, Bertotto I, Montemurro F, et al,. Variation of breast vascular maps on dynamic contrast-enhanced MRI after primary chemotherapy of locally advanced breast cancer. AJR Am J Roentgenol 2011; 196: 1214-8.
32. Grady I, Gorsuch-Rafferty H, Hadley P,. Preoperative staging with magnetic resonance imaging, with confirmatory biopsy, improves surgical outcomes in women with breast cancer without increasing rates of mastectomy. Breast J 2012; 18: 214-8.